Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells
OA Location
Author(s)
Matthews, NC
Goodier, MR
Robey, RC
Bower, M
Gotch, FM
Type
Journal Article
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) establishes life-long infection by evading clearance by the host immune system. In de novo infection and lytic replication, KSHV escapes cytotoxic T cells and NK cells through downregulation of MHC class-I and ICAM-1 molecules and associated antigens involved in forming and sustaining the immunological synapse. However, the efficacy of such mechanisms in the context of the predominantly latent KSHV infection reported in Kaposi's sarcoma (KS) lesions is unclear. Using primary dermal fibroblasts in a novel in vitro model of chronic latent KSHV infection, we generated target cells with viral loads similar to those in spindle cells extracted from KS lesions. We show that latently KSHV-infected fibroblasts had normal levels of MHC-class I, ICAM-1, HLA-E and NKG2D ligand expression, were resistant to NK-cell natural cytotoxicity and were highly susceptible to killing by cytokine-activated immunocompetent NK cells. KSHV-infected fibroblasts expressed normal levels of IFN-γR1 and responded to exogenous IFN-γ by upregulating MHC class I, ICAM-1 and HLA-E and resisting activated NK-cell killing. These data demonstrate that physiologically relevant levels of latent KSHV infection in primary cells cause limited activation of resting NK cells and confer little specific resistance to control by activated NK cells.
Date Issued
2011-05-27
Date Acceptance
2011-04-13
Citation
European Journal of Immunology, 2011, 41 (7), pp.1958-1968
ISSN
1521-4141
Publisher
Wiley-VCH Verlag
Start Page
1958
End Page
1968
Journal / Book Title
European Journal of Immunology
Volume
41
Issue
7
Copyright Statement
© 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Sponsor
Medical Research Council (MRC)
Grant Number
G0501957
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
IMMUNOLOGY
Immune evasion
Kaposi's sarcoma-associated herpesvirus
NK cells
T-LYMPHOCYTE EPITOPES
DE-NOVO INFECTION
COMPLEX CLASS-I
ANTIRETROVIRAL THERAPY
HUMAN CYTOMEGALOVIRUS
ENDOTHELIAL-CELLS
DOWN-REGULATION
LYTIC REPLICATION
DNA-SEQUENCES
AIDS PATIENTS
Cells, Cultured
Cytokines
Cytotoxicity, Immunologic
Fibroblasts
Flow Cytometry
Gene Expression
HLA Antigens
Herpesvirus 8, Human
Histocompatibility Antigens Class I
Humans
Intercellular Adhesion Molecule-1
Interferon-gamma
Killer Cells, Natural
Lymphocyte Activation
NK Cell Lectin-Like Receptor Subfamily K
Phenotype
Polymerase Chain Reaction
Sarcoma, Kaposi
Virus Latency
1107 Immunology
Publication Status
Published